RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

Wed, 22 Jul 2026 06:00:00 -0400

LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Investors are invited to listen to RadNet’s conference call by dialing 844-744-1280. International callers can dial 412-564-6465. There will also be simultaneous and archived webcasts available at

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

Wed, 22 Jul 2026 06:00:00 -0400

DeepHealth gets FDA clearance for two new breast imaging AI tools

Thu, 25 Jun 2026 06:00:38 -0400

DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received two FDA 510(k) clearances for new functionalities within its Breast Suite AI platform, according to a company statement.

The first clearance covers Breast Arterial Calcification (BAC) Assessment, a tool that automatically identifies breast arterial calcifications on standard 2D and 3D screening mammograms without requiring additional imaging. Breast arterial calcifications visible on mammograms have been linked to an elevated risk of cardiovascular events including heart attacks and strokes. In clinical performance testing, the tool demonstrated more than 90% sensitivity and more than 88% specificity in identifying arterial calcifications across both dense

DeepHealth gets FDA clearance for two new breast imaging AI tools

Thu, 25 Jun 2026 06:00:38 -0400

DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received two FDA 510(k) clearances for new functionalities within its Breast Suite AI platform, according to a company statement.

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Thu, 25 Jun 2026 06:00:00 -0400

New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions

SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite¹ functionalities:

Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;²
Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Thu, 25 Jun 2026 06:00:00 -0400

New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions

Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;²
Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Thu, 25 Jun 2026 06:00:00 -0400

New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions

Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;²
Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Thu, 25 Jun 2026 06:00:00 -0400

New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions

Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;²
Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies

Form 4 RadNet, Inc. For: Jun 18 Filed by: SWARTZ DAVID L

Mon, 22 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260622/26673294.html

Form 4 RadNet, Inc. For: Jun 18 Filed by: SWARTZ DAVID L

Mon, 22 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260622/26673294.html

Form 4 RadNet, Inc. For: Jun 16 Filed by: Wesdorp Cornelis

Thu, 18 Jun 2026 18:03:00 -0400

si-local-file:///var/storage/secattach/20260618/26667501.html

Form 4 RadNet, Inc. For: Jun 16 Filed by: Wesdorp Cornelis

Thu, 18 Jun 2026 18:03:00 -0400

si-local-file:///var/storage/secattach/20260618/26667501.html

Form 4 RadNet, Inc. For: Jun 16 Filed by: Berger Howard G

Thu, 18 Jun 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260618/26667494.html

Form 4 RadNet, Inc. For: Jun 16 Filed by: Berger Howard G

Thu, 18 Jun 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260618/26667494.html

Form 144 RadNet, Inc. Filed by: SWARTZ DAVID L

Thu, 18 Jun 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26667416.html

Form 144 RadNet, Inc. Filed by: SWARTZ DAVID L

Thu, 18 Jun 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26667416.html

Form 144 RadNet, Inc. Filed by: Wesdorp Cornelis

Tue, 16 Jun 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260616/26654749.html

Form 144 RadNet, Inc. Filed by: Wesdorp Cornelis

Tue, 16 Jun 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260616/26654749.html

Form 4 RadNet, Inc. For: Jun 15 Filed by: Forthuber Stephen M

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654298.html

Form 4 RadNet, Inc. For: Jun 15 Filed by: Forthuber Stephen M

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654298.html

Form 144 RadNet, Inc. Filed by: Forthuber Stephen M

Mon, 15 Jun 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260615/26648061.html

Form 144 RadNet, Inc. Filed by: Forthuber Stephen M

Mon, 15 Jun 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260615/26648061.html

Form 8-K RadNet, Inc. For: Jun 10

Wed, 10 Jun 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260610/26630938.html

Form 8-K RadNet, Inc. For: Jun 10

Wed, 10 Jun 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260610/26630938.html

RadNet secures $250 million term loan, cuts interest rates

Wed, 10 Jun 2026 16:05:14 -0400

RadNet Inc. (NASDAQ: RDNT) obtained a $250 million incremental term loan through an amendment to its existing credit agreement, the company announced. The diagnostic imaging services provider also reduced interest rates on its credit facilities by 0.25%.

The new term loan matures on April 18, 2031, matching the maturity date of RadNet's existing $958.7 million term loan balance. Quarterly principal payments will increase to approximately $3.1 million from $2.4 million previously.

RadNet plans to use the proceeds for acquisitions, organic expansion initiatives, health system partnerships and general corporate purposes. The company's interest rate on the combined term loan decreased to Term SOFR

StreetInsider.com News Articles

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

DeepHealth gets FDA clearance for two new breast imaging AI tools

DeepHealth gets FDA clearance for two new breast imaging AI tools

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Form 4 RadNet, Inc. For: Jun 18 Filed by: SWARTZ DAVID L

Form 4 RadNet, Inc. For: Jun 18 Filed by: SWARTZ DAVID L

Form 4 RadNet, Inc. For: Jun 16 Filed by: Wesdorp Cornelis

Form 4 RadNet, Inc. For: Jun 16 Filed by: Wesdorp Cornelis

Form 4 RadNet, Inc. For: Jun 16 Filed by: Berger Howard G

Form 4 RadNet, Inc. For: Jun 16 Filed by: Berger Howard G

Form 144 RadNet, Inc. Filed by: SWARTZ DAVID L

Form 144 RadNet, Inc. Filed by: SWARTZ DAVID L

Form 144 RadNet, Inc. Filed by: Wesdorp Cornelis

Form 144 RadNet, Inc. Filed by: Wesdorp Cornelis

Form 4 RadNet, Inc. For: Jun 15 Filed by: Forthuber Stephen M

Form 4 RadNet, Inc. For: Jun 15 Filed by: Forthuber Stephen M

Form 144 RadNet, Inc. Filed by: Forthuber Stephen M

Form 144 RadNet, Inc. Filed by: Forthuber Stephen M

Form 8-K RadNet, Inc. For: Jun 10

Form 8-K RadNet, Inc. For: Jun 10

RadNet secures $250 million term loan, cuts interest rates